FDA Protects Covid-19 Vaccine Makers Seeks Withdrawal Of Competing Dietary Supplement

Amazon Appeases FDA Removes Sulfur-Based Dietary Supplement From Online Offerings Because It Cures COVID-19 And Threatens Vaccine Emergency-Use Provisions.

Late last year (2020) the FDA issued a warning letter that a sulfur-based dietary supplement couldn’t be lawfully marketed because it was first studied as a drug in 1963 and marketed in that same year under the trade name Mucomyst to break up mucus accumulation in the upper respiratory tract (bronchus, lung).

The dietary supplement industry legally challenged the FDA over this categorical restriction for use solely as a drug to treat disease to the exclusion of its use to promote health, which is the what dietary supplements are permitted to claim......'


[link to www.lewrockwell.com (secure)]